The contribution of PTEN inactivation as a mechanism of PI3K pathway activation in AML is controversial; although PTEN is deleted in many solid cancers and T-cell acute lymphoblastic leukemia, PTEN deletion is extremely rare in AML [41–43]. The gene discussed is PTEN; the disease is acute myeloid leukemia.